Dr Marie-Christine Klein
Head of Development & Regulatory Affairs

Is this your profile?

About

Marie-Christine Klein, PhD, is a biologist by training and joined URSATEC in 2019. She leads the development and regulatory affairs team that is focusing on innovative developments in combination with the URSATEC application technology.

Contributions

BREEASE – DESIGNED TO ALLEVIATE BREATHING FOR INFANTS AND TODDLERS

Marie-Christine Klein, Christian Weyler and Dr Fredrik Bokvist, discuss the effects of air pollution on health – and how the Breease pacifier could help babies and young children.

More contributions

TOWARDS A COMPREHENSIVE SUSTAINABILITY STRATEGY

Marie-Christine Klein and Christian Weyler, look at the evolution of the company’s sustainability strategy within its regulatory and economic framework – and what decarbonisation means for the pharmaceutical industry.

CHALLENGES BESIDES DRUG TARGETING – REGULATORY HURDLES FOR MULTIDOSE NASAL SPRAYS

Marie-Christine Klein, Andreas Bilstein and Rouven Kraus, discuss recent regulatory changes affecting drug-device combination products, using the example of a multidose nasal spray.

THE APPLICATION DIVERSITY OF METERED PUMP-BASED SOFT MIST DEVICES

Marie-Christine Klein, Andreas Bilstein and Caroline Hoffmann discuss the underlying techniques involved in the use of metered pump-based soft mist devices and their application diversity.

“PRESERVATIVE FREE” – THE SKIN MICROBIOME’S CLOSE FRIEND

Marie-Christine Klein, Andreas Bilstein and Julia Krüger discuss the effects of preservatives on the skin microbiome and consider new technologies that minimise the percentage of preserving agents used in cosmetic formulations.

NOSE-TO-BRAIN DRUG ADMINISTRATION AND A NOVEL APPROACH WITH AN OLD FAMILIAR

Marie-Christine Klein, Andreas Bilstein and Rouven Kraus look at the advantages of the nose-to-brain route and soft mist nasal sprays for drug administration.

Top